REED JOHN C
EVP, Innovative Medicine, R&D · 14 insider transactions on file
All transactions
| Date | Ticker | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-05-01 | JNJ | JOHNSON & JOHNSON | Tax withholding | 11,002 | $229.85 | $2.5M | filing |
| 2026-05-01 | JNJ | JOHNSON & JOHNSON | Option exercise | 25,255 | $0.00 | $0.00 | filing |
| 2026-02-17 | JNJ | JOHNSON & JOHNSON | Sale | 29,927 | $243.00 | $7.3M | filing |
| 2026-02-17 | JNJ | JOHNSON & JOHNSON | Sale | 21,721 | $243.00 | $5.3M | filing |
| 2026-02-17 | JNJ | JOHNSON & JOHNSON | Option exercise | 29,927 | $156.15 | $4.7M | filing |
| 2026-02-17 | JNJ | JOHNSON & JOHNSON | Option exercise | 21,721 | $157.92 | $3.4M | filing |
| 2026-02-17 | JNJ | JOHNSON & JOHNSON | Sale | 2,283 | $243.00 | $554,769.00 | filing |
| 2026-02-15 | JNJ | JOHNSON & JOHNSON | Tax withholding | 528 | $243.45 | $128,541.60 | filing |
| 2026-02-15 | JNJ | JOHNSON & JOHNSON | Tax withholding | 385 | $243.45 | $93,728.25 | filing |
| 2026-02-15 | JNJ | JOHNSON & JOHNSON | Option exercise | 1,349 | $0.00 | $0.00 | filing |
| 2026-02-15 | JNJ | JOHNSON & JOHNSON | Option exercise | 1,847 | $0.00 | $0.00 | filing |
| 2025-10-17 | JNJ | JOHNSON & JOHNSON | Sale | 21,721 | $192.71 | $4.2M | filing |
| 2025-10-17 | JNJ | JOHNSON & JOHNSON | Option exercise | 21,721 | $157.92 | $3.4M | filing |
| 2025-07-17 | JNJ | JOHNSON & JOHNSON | Sale | 19,137 | $163.55 | $3.1M | filing |
Insider transactions from SEC Form 4 filings via EDGAR. Names appear as filed and aren't normalized across issuers.